MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome (Q43462890)

23 November 2017

MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome (English)

1 reference

tonsillar squamous cell carcinoma

23 November 2017

1 reference

1

1 reference

23 November 2017

Emilia Andersson

2

1 reference

23 November 2017

Cecilia Nordfors

3

1 reference

23 November 2017

Nathalie Grün

4

1 reference

23 November 2017

Hemming Johansson

5

1 reference

23 November 2017

Eva Munck-Wikland

6

1 reference

23 November 2017

Giuseppe Massucci

7

1 reference

23 November 2017

Tina Dalianis

8

1 reference

23 November 2017

Torbjörn Ramqvist

9

1 reference

23 November 2017

language of work or name

English

0 references

publication date

7 June 2012

1 reference

International Journal of Cancer

23 November 2017

1 reference

23 November 2017

132

1 reference

23 November 2017

72-81

1 reference

23 November 2017

1

1 reference

Oropharyngeal cancer epidemic and human papillomavirus

23 November 2017

1 reference

Changing patterns of tonsillar squamous cell carcinoma in the United States

21 January 2018

1 reference

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

21 January 2018

1 reference

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years

21 January 2018

1 reference

The molecular biology of head and neck cancer

21 January 2018

1 reference

Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.

21 January 2018

1 reference

Role of molecular markers in the management of head and neck cancers

21 January 2018

1 reference

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

21 January 2018

1 reference

21 January 2018

Cancer of the oropharynx

1 reference

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

21 January 2018

1 reference

Prognostic impact of anticancer immune responses: an introduction

21 January 2018

1 reference

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

21 January 2018

1 reference

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.

21 January 2018

1 reference

The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells

21 January 2018

1 reference

HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

21 January 2018

1 reference

HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter

21 January 2018

1 reference

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

21 January 2018

1 reference

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.

21 January 2018

1 reference

The role of HLA-G in immunity and hematopoiesis.

21 January 2018

1 reference

Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer.

21 January 2018

1 reference

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

21 January 2018

1 reference

The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules

21 January 2018

1 reference

Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents.

21 January 2018

1 reference

Expression of HLA class I molecules in human first trimester and term placenta trophoblast

21 January 2018

1 reference

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

21 January 2018

1 reference

Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.

21 January 2018

1 reference

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

21 January 2018

1 reference

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

21 January 2018

1 reference

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

21 January 2018

1 reference

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27635

1 reference

23 November 2017

1 reference